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Synovial sarcoma is a malignant, predominantly juxta-articular, soft-tissue tumour 
representing approximately 10% of all soft-tissue sarcomas. Frequently initially incorrectly 
diagnosed as a benign lesion, it should be considered as a diagnosis when a young adult 
patient presents with a calcified juxta-articular soft-tissue mass of insidious onset.
Introduction
Synovial sarcoma was first reported in 18931 and named after its microscopic resemblance to 
normal synovium.2 It is thought to originate from primitive mesenchymal cells that undergo 
differentiation to resemble synovial cells.2,3,4,5
Synovial sarcomas usually occur in adolescents and young adults, with no gender or racial 
predilection.2,3,4 They typically affect the extremities (80%–95% of cases),4 arising from tendons, 
tendon sheets and bursal structures. It is important to note that they usually arise beyond the 
confines of the joint capsule. The single most commonly affected site is the knee.2,3,4,5,6
Synovial sarcomas are frequently initially incorrectly diagnosed as benign processes such as 
myositis, synovitis, haematoma, tendinitis or bursitis,2 resulting in the time to final diagnosis 
ranging from two to four years.4 It is therefore important to consider synovial sarcoma when 
a young adult patient presents with a calcified juxta-articular soft-tissue mass of insidious 
onset.5
Case report
A 14-year-old boy presented at initial consultation with a one-year history of a tender, slow-
growing, juxta-articular left knee mass. Conventional radiographs revealed a soft-tissue mass 
with coarse calcifications (Figure 1). Magnetic resonance imaging (MRI) displayed a soft-tissue 
mass with heterogeneous T1 and T2 signal characteristics (Figure 2). An excision biopsy, followed 
by haematoxylin and eosin staining (Figure 3) and subsequent examinations, was performed 
in order to establish the diagnosis. The cells were positive for MNF (a pan-epithelial marker), 
EMA (epithelial membrane antigen), CD99 and bcl2. FISH (fluorescence in situ hybridisation) 
was positive, confirming the diagnosis of synovial sarcoma.
Discussion
Synovial sarcoma is a slow-growing, high-grade malignant neoplasm with extensive metastatic 
potential.4,5 It accounts for approximately 10% of all soft-tissue sarcomas3 and occurs predominantly 
in adolescents and young adults between the ages of 15 and 40 years.2,3,4,5
The extremities are affected in 95% of cases, and the lower limb in 70% of the former.6 The 
neoplasms usually occur in close proximity to large joints of the extremities, predominantly 
around the knee,2,3,4,5,6,7 followed by the ankle, elbow and shoulder.2 They rarely occur in the head, 
neck, thorax and abdomen.3
Synovial sarcomas are usually found in close association with tendon sheets, bursae and joint 
capsules, but joint involvement is rare.2 When intra-articular involvement does occur, it usually 
extends from an extra-articular site into the joint space.4,5
Patients most commonly present with insidious onset of a peri-articular, palpable, deep-seated 
swelling or mass that is commonly associated with pain or tenderness.2,3,4,5,6,7 The duration of 
symptoms varies from weeks to decades, with an average duration of 2–4 years.2,3,4
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FIGURE 1: Anteroposterior (a) and lateral (b) radiographs of the left knee display a soft-tissue mass anteromedial to the proximal tibia (red arrows) of an adolescent 
patient. Note the coarse calcifications (blue arrow, AP view).
ba
FIGURE 2: Sagittal (a) and axial (b) T1W images reveal mixed iso- and hyperintense changes within the soft-tissue mass (green arrows) owing to haemorrhage, without 
bony or subcutaneous fat involvement.
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Metastases are present in a quarter of patients at initial 
diagnosis,5 and mainly affect the lungs2,3,4,5 and, to a lesser 
extent, lymph nodes, bone and rarely the liver or brain.3
Conventional radiographs may appear normal in 
approxi mately 50% of cases.4 Typical radiographic features 
include a juxta-articular soft-tissue mass within 5 cm of the 
joint and amorphous calcifications in 20%–30% of cases, 
which are often eccentric or peripheral.4 An associated 
periosteal reaction is present in 15%–20% of cases.2,3,4,5,6,7
Computed tomography (CT) scanning shows a soft-tissue 
mass with or without calcifications and bony involve-
ment.2,3,4,5,6,7 MRI is reserved for local staging of the extent of 
the disease.
Characteristic changes include a heterogeneous, multi-
lobulated soft-tissue mass with a signal intensity similar to or 
slightly higher than that of muscle on T1W, and a mixed high, 
intermediate, low signal on T2W that has been described as 
the triple sign. Fluid-fluid levels are seen in 25% of cases.2,3,4,5,6
Fluorodeoxyglucose positron emission tomography (FDG-
PET) is helpful in differentiating recurrent tumour from 
post-therapeutic changes, and is valuable in determining 
prognosis.3,7
It is important to note that imaging appearances are largely 
non-specific; biopsy is always necessary for the final 
diagnosis. At our institution, this is the domain of the 
clinician and not the radiologist. The current treatment of 
choice is surgery with or without radiotherapy. The use of 
chemotherapy is controversial.3,5
Teaching point
Synovial sarcoma features prominently in the differential 
diagnosis of a soft-tissue tumour around the knee in a young 
patient.
Conclusion
Synovial sarcoma represents approximately 10% of all soft-
tissue sarcomas and must be considered in addition to other 
sarcomas when adolescents or young adults present with 
insidious onset of a calcified juxta-articular mass, especially 
around the knee.
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FIGURE 3: Haematoxylin and eosin staining, X 100 magnification. Overlapping 
spindle cells with scanty cytoplasm and hyperchromatic nuclei. Some of the 
cells formed small nests (white arrows) reminiscent of epithelial differentiation. 
Also present are stag horn blood vessels with a haemangiopericytic pattern 
(black arrow).
